Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/29/2012US20120301487 Method for in-vivo binding of chromatin fragments
11/29/2012US20120301486 Compositions and methods for inhibition of the jak pathway
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301484 Regulatory t cell mediator proteins and uses thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301482 Methods and compositions for treatment of lung injury
11/29/2012US20120301481 Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections
11/29/2012US20120301480 H. pylori lipopolysaccharide outer core epitope
11/29/2012US20120301478 Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability
11/29/2012US20120301477 USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
11/29/2012US20120301476 Pharmaceutical composition for treating and/or preventing cancer
11/29/2012US20120301475 Novel heparanase splice variant
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301473 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301471 Pharmaceutical composition for treating and/or preventing cancer
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301468 Anti-mn antibodies and methods of using same
11/29/2012US20120301467 Fas binding antibodies
11/29/2012US20120301466 Chemically programmable immunity
11/29/2012US20120301465 Compositions and methods to immunize against hepatitis c virus
11/29/2012US20120301464 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301462 Compounds
11/29/2012US20120301461 1d05 pcsk9 antagonists
11/29/2012US20120301460 Subcutaneously administered anti-il-6 receptor antibody
11/29/2012US20120301459 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
11/29/2012US20120301458 Cyclopropyl modulators of p2y12 receptor
11/29/2012US20120301431 Methods of treating a disease or condition associated with abnormal angiogenesis
11/29/2012US20120301430 Thiophene analogues for the treatment or prevention of flavivirus infections
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301428 Clostridium gene
11/29/2012US20120301404 Treatment of cachexia
11/29/2012US20120301400 Meditopes and meditope-binding antibodies and uses thereof
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012US20120301394 Targeting and in vivo imaging of tumor-associated macrophages
11/29/2012CA2837184A1 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
11/29/2012CA2837145A1 Inactivated dengue virus vaccine
11/29/2012CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012CA2836926A1 Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha
11/29/2012CA2836898A1 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
11/29/2012CA2836873A1 Deimmunized serum-binding domains and their use for extending serum half-life
11/29/2012CA2836800A1 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012CA2836799A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012CA2836649A1 Anti-cgrp compositions and use thereof
11/29/2012CA2836494A1 Individualized vaccines for cancer
11/29/2012CA2834589A1 Method for preparing fc-containing polypeptides having improved properties
11/29/2012CA2834442A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2834440A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2825333A1 Antagonism of the vip signaling pathway
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012EP2527429A2 DAC HYP compositions and methods
11/28/2012EP2527370A1 Compounds having resistance to soluble CEA
11/28/2012EP2527369A2 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
11/28/2012EP2527366A1 Monoclonal anti beta amyloid antibody
11/28/2012EP2527364A1 Crystalline anti-human IL-12 antibodies
11/28/2012EP2527363A1 Vaccines based on targeting antigen to dcir expressed on antigen-presenting cells
11/28/2012EP2526970A1 Monitoring cancer stem cells
11/28/2012EP2526969A1 Monitoring cancer stem cells
11/28/2012EP2526968A2 Nogo receptor antagonists
11/28/2012EP2526967A1 Engineered anti-alpha v-integrin hybrid antibodies
11/28/2012EP2526966A2 Herpes simplex virus combined subunit vaccines and methods of use thereof
11/28/2012EP2526965A1 Immunisation method against the 4 Dengue serotypes
11/28/2012EP2526964A1 Immunisation method against the 4 Dengue serotypes
11/28/2012EP2526963A1 Solution preparation containing stabilized antibody
11/28/2012EP2526959A1 Treatment of pulmonary disease conditions
11/28/2012EP2526951A1 Rhamno-polysaccharide from Enterococcus faecium clonal complex 17 and uses thereof
11/28/2012EP2526946A1 Methods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione For Treatment Of Certain Leukemias
11/28/2012EP2526421A2 Detection of early-stage pancreatic adenocarcinoma
11/28/2012EP2526185A1 BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
11/28/2012EP2526114A1 Chromatographic method for purifying fc-containing proteins
11/28/2012EP2525832A1 Cancer stem cell markers and uses thereof
11/28/2012EP2525826A2 Pharmaceutical formulation for proteins
11/28/2012EP2525823A1 Delivery system for diagnostic and therapeutic agents
11/28/2012EP2525822A1 Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments
11/28/2012EP2525821A1 Tumor tissue based biomarkers for bevacizumab combination therapies
11/28/2012EP2525820A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
11/28/2012EP2525819A2 Immunotherapy compositions and methods of treatment
11/28/2012EP2525818A2 Immunogenic influenza composition
11/28/2012EP2525817A1 Vaccine vectors and methods of enhancing immune responses
11/28/2012EP2525816A2 Targeted heterologous antigen presentation on calicivirus virus-like particles
11/28/2012EP2525815A1 Irradiated biodegradable polymer microparticles
11/28/2012EP2525814A2 Methods of treating or preventing periodontitis and diseases associated with periodontitis
11/28/2012EP2525813A1 Anti-ilt5 antibodies and ilt5-binding antibody fragments
11/28/2012EP2525812A2 Anticoagulant antidotes
11/28/2012EP2525811A1 Nutritional formulas containing synbiotics
11/28/2012EP2525800A1 Enterococcal cell wall components and antibacterial use thereof
11/28/2012EP2463368A9 Humanized anti-amyloid-b oligomer antibody
11/28/2012CN1997394B Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
11/28/2012CN1930184B Novel TAT complexes, and vaccines comprising them
11/28/2012CN102803294A Anti-ASCT2 (system ASC amino acid transporter type 2) antibody
11/28/2012CN102803293A SIGLEC 15 antibodies in treating bone loss-related disease
11/28/2012CN102803292A Control Of Protein Glycosylation And Compositions And Methods Relating Thereto
11/28/2012CN102802667A Method for treating immune disorders
11/28/2012CN102802666A Swine Influenza Hemagglutinin Variants
11/28/2012CN102802665A Influenza vaccine, composition, and methods of use
11/28/2012CN102802664A Immunogenic compositions
11/28/2012CN102802663A Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
11/28/2012CN102802662A Adjuvanted vaccines for serogroup B meningococcus
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1823